Amendment: SEC Form SC 13G/A filed by Oncocyte Corporation

 Name of Reporting Person:

  PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015

 I.R.S. Identification No. of above Person (entities only) (voluntary)

 Check the Appropriate Box if a Member of a Group

 (a) ☐  (b) ☐

 SEC USE ONLY

 Citizenship or Place of Organization

 Arizona

NUMBER OF

SHARES

BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

 SOLE VOTING POWER

 0

 SHARED VOTING POWER

 1,558,437

 SOLE DISPOSITIVE POWER

 0

 SHARED DISPOSITIVE POWER

 1,558,437

 AGGREGATE AMOUNT BENEFICIALLY OWNED

 1,558,437

 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 ☐

 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 9.3%

 TYPE OF REPORTING PERSON

 OO

 Names of Reporting Person:

 Patrick W. Smith

 I.R.S. Identification No. of above Person (entities only) (voluntary)

 Check the Appropriate Box if a Member of a Group

 (a) ☐  (b) ☐

 SEC USE ONLY

 Citizenship or Place of Organization

 United States of America

NUMBER OF

SHARES

BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

 SOLE VOTING POWER

 0

 SHARED VOTING POWER

 1,558,437

 SOLE DISPOSITIVE POWER

 0

 SHARED DISPOSITIVE POWER

 1,558,437

 AGGREGATE AMOUNT BENEFICIALLY OWNED

 1,558,437

 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 ☐

 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 9.3%

 TYPE OF REPORTING PERSON

 IN

Name of Issuer:

Oncocyte, Inc.

Address of Issuer’s Principal Executive Offices:

15 Cushing, Irving, California 92618

Name of Persons Filing:

This Schedule 13G/A is being filed by and on behalf of (i) PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the “Trust”), and (ii) Patrick W. Smith, as trustee of the Trust (each, a “Reporting Person” and collectively, the “Reporting Persons”).

The Reporting Persons have entered into a Joint Filing Agreement, dated October 9, 2024, a copy of which is incorporated by reference as Exhibit A to the Schedule 13G filed by the Reporting Persons on October 9, 2024, pursuant to which the Reporting Persons agreed to file this Schedule 13G/A and any amendments hereto jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Act of 1933, as amended.

Address of Principal Business Office, or if None, Residence:

c/o Patrick Smith, TTEE, 11445 E. Via Linda, Suite 2-411, Scottsdale, AZ 85259

Citizenship:

The Trust is formed under the laws of the State of Arizona. Patrick W. Smith is a citizen of the United States.

Title of Class of Securities:

Common Stock, no par value.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is:

Not Applicable.

Ownership:

(a) through (c):

The information requested herein is incorporated by reference to the cover pages to this Schedule 13G/A. Percentage ownership is based on 16,835,247 shares of Common Stock outstanding as of November 5, 2024, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the Securities and Exchange Commission on November 12, 2024.

The shares reported herein are directly held by the Trust. As the trustee of the Trust, Patrick W. Smith may be deemed to beneficially own the securities held by the Trust. Patrick W. Smith disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.

Ownership of Five Percent or Less of the Class:

Not Applicable.

Ownership of More Than Five Percent on Behalf of Another Person:

Not Applicable.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not Applicable.

Identification and Classification of Members of the Group:

Not Applicable.

Notice of Dissolution of Group:

Not Applicable.

Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.